1. HOME
  2. Guide for Visitors
  3. Department of Clinical Neuroscience -
    Neurology and Cerebrovascular Diseases

Neurology and Cerebrovascular Diseases

Specialized medical services

MOCHIZUKI Hideki Director of Neurology and Cerebrovascular Diseases

MOCHIZUKI Hideki
Director of Neurology and
Cerebrovascular Diseases

We provide medical care services to many patients with degenerative diseases such as Parkinson’s disease, amyotrophic lateral sclerosis (ALS), spinocerebellar degeneration, and dementia; autoimmune nervous diseases such as multiple sclerosis (MS) and myasthenia gravis; metabolic muscle diseases such as mitochondrial encephalomyopathy; peripheral neuropathy such as Guillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), and Charcot-Marie-Tooth disease; epilepsy, migraine and involuntary movement.
To treat cerebrovascular disorder (stroke), non-invasive test methods including imaging procedure and ultrasonography are applied to patients who are at the chronic stage or at risk of showing no symptoms, in order to provide the most suitable primary/recurrent stroke prevention. At the acute stage, we strive to proactively apply thrombolytic therapy with tPA intravenous injection, rapid diagnosis of disease type, and acute-stage rehabilitation to stroke patients. The number of beds was increased to three in the SCU in 2010 to provide stroke patients at the acute stage with further improved medical services, including treatment, nursing care, and rehabilitation services.
As described above, we treat patients with all neurological diseases excluding psychiatric disorders.

Features

We provide the therapy most appropriate for each pathological condition; for example, advanced medical care services to patients with degenerative diseases including Parkinson’s disease; thorough rehabilitation; improved functional prognosis; botulinum toxin treatment for patients with involuntary movement; and self-injection therapy with interferon and intravenous immuno globulin (IVIG) in patients with neuroimmunological diseases.
In addition to the Trauma and Acute Critical Care Center and Neurosurgery, the Stroke Center formed in 2005 promptly treats acute-stage stroke patients.
We diagnose and treat patients with neurological disease induced by neuro-Behcet’s disease, sarcoidosis, collagen disorders, and diabetes mellitus in cooperation with other clinical sections concerned.

HOME

Guide for Visitors
Outpatient consultation days
Monday to Friday
Non-consultation days
Saturdays, Sundays, Holidays
New Year’s Holidays:
Dec. 29 to Jan. 3
Consultation times
First visit: 8:30 am to 11:00 am

First-time visitors to Osaka University Hospital must have a referral from a physician.

Revisit: 8:30 am to 11:30 am
Revisit with appointment: 8:30 am to 3:00 pm

Page Top

We cannot answer questions about diseases or treatments by telephone or mail. Please ask in consultation at the hospital.